•  
• Tweet
•  
•  
•        Print
•  
•        Email
•  
•         Track Keywords

"The hedge fund industry continues to show broad strength," says Sol Waksman, founder and president of BarclayHedge. "The continued rally in the U.S. equity market combined with outsized returns in specific market segments have led the industry higher this year."

Healthcare leads, global macro lags

Overall, 13 of 17 subindices showed gains in June. Among the winners, Healthcare and Biotechnology led all subcategories with a 5.32% gain, followed by Pacific Rim Equities with a gain of 1.85% and Equity Long Bias at 0.85%. Sectors with the greatest losses were Technology (-1.21), Global Macro (-0.74%), and Distressed Securities (-0.13%).

In addition to being the top performing area in June, Healthcare and Biotechnology also leads all sectors year to date with a gain of 11.92%. Technology is the second best performing sector for the year, with a solid 11.08% gain despite a dip in June. Other solid winners for the year include Emerging Markets (8.24%) and European Equities (6.00%). Global macro, on the other hand, continues to take it on the chin. In addition to recording the worst performance in June it is the only sub-index that is in negative territory for the year to date (-0.15%).

"2017 has been an interesting year for the hedge fund industry," says Waksman. "While the U.S. market has remained strong, recent attention has been focused in emerging markets and Europe. We've seen positive returns in a period of historically low volatility; it will be interesting to see how markets perform if volatility picks up."